Show source-provided references
1. Culture of Leishman body isolated from taxa in three cases of childhood anemia
5. (2025, April 02). Brazil. Ministry of Health. Epidemiological Indicators of Leishmaniasis. Brasília: SVS/MS; 2023, Available online: https://www.gov.br/saude.
6. Epidemiological aspects of canine visceral leishmaniasis in the rural area of the semi-arid region of Paraíba and analysis of diagnostic techniques
7. Ministry of Health, Secretariat of Health Surveillance, and Department of Epidemiological Surveillance (2014). Manual of Surveillance and Control of Visceral Leishmaniasis.
8. Ministry of Health, Health Surveillance Secretariat (2025, August 01). Joint Technical Note 01/2011 CGDT/CGLAB/DEVIT/SVS/MS of 29 December 2011. Available online: https://crmvms.org.br/wp-content/uploads/2019/10/nota-tecnica-no.-1-2011_cglab_cgdt1_lvc_98999048.pdf.
10. Maurelli, M.P., Bosco, A., Manzillo, V.F., Vitale, F., Giaquinto, D., Ciúca, L., Molinaro, G., Cringoli, G., Oliva, G., and Rinaldi, L. (2020). Clinical, molecular and serological diagnosis of canine leishmaniasis: An integrated approach. Vet. Sci., 7.
10.3390/vetsci7020043 ↗11. (2018). Diagnosis of canine visceral leishmaniasis: Comparative performance of serological and molecular tests in symptomatic and asymptomatic dogs. Epidemiol. Infect., 146, 571–576.
10.1017/S0950268818000225 ↗12. Parasite density and impaired biochemical/hematological status are associated with severe clinical features of canine visceral leishmaniasis
10.1016/j.rvsc.2005.09.011 ↗13. CD4+ T lymphocytes from asymptomatic dogs infected with Leishmania infantum are capable of activating macrophages for greater leishmanicidal capacity in an in vitro co-culture experiment
10.1016/j.molimm.2022.08.013 ↗15. Martins, V.T., Chávez-Fumagalli, M.A., Costa, L.E., Martins, A.M.C.C., Lage, P.S., Lage, D.P., Duarte, M.C., Valadares, D.G., Magalhães, R.D.M., and Ribeiro, T.G. (2013). Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, a member of the superoxygenase family, against visceral leishmaniasis. PLoS Negl. Trop. Dis., 7.
10.1371/journal.pntd.0002148 ↗16. Carvalho, A.M.R.S., Mendes, T.A.O., Coelho, E.A.F., Duarte, M.C., and Menezes-Souza, D. (2018). Novel antigens for the serological diagnosis of human visceral leishmaniasis identified by immunogenomic screening. PLoS ONE, 13.
10.1371/journal.pone.0209599 ↗17. Dias, D.S., Machado, J.M., Ribeiro, P.A.F., Machado, A.S., Ramos, F.F., Nogueira, L.M., Gonçalves, A.A.M., Ramos, L.d.S., Gandra, I.B., and Coutinho, F.S. (2023). rMELEISH: A new recombinant protein based on multiepitopes applied to the serodiagnosis of canine and human visceral leishmaniasis. Pathogens, 12.
10.3390/pathogens12020302 ↗18. A rapid and sensitive method for the quantification of micrograms of protein using the principle of protein-dye binding
10.1016/0003-2697(76)90527-3 ↗19. Costa, A.T. (2024). Evaluation of Biomarkers Predictive of the Capacity of Dogs with Visceral Leishmaniasis to Act as a Reservoir for Parasite Transmission to Sand Flies. [Ph.D. Thesis, Universidade Federal de Minas Gerais].
20. Ottino, J., Leite, J.C., Melo-Júnior, O.A., González, M.A.C., de Carvalho, T.F., Garcia, G.M., Batista, M.A., Silveira, P., Cardoso, M.S., and Bueno, L.L. (2022). Nanoformulations with Leishmania braziliensis antigens triggered controlled parasite burden in vaccinated golden hamsters (Mesocricetus auratus) against visceral leishmaniasis. Vaccines, 10.
10.3390/vaccines10111848 ↗22. Rosano, G.L., and Ceccarelli, E.A. (2014). Recombinant protein expression in Escherichia coli: Advances and challenges. Front. Microbiol., 5.
10.3389/fmicb.2014.00172 ↗23. High-throughput quantitative expression screening and purification applied to recombinant disulfide-rich venom proteins produced in E. coli
25. Nelson, D.L., and Cox, M.M. (2021). Lehninger ‘s Principles of Biochemistry, Artmed. [8th ed.].
26. Understanding anomalous protein mobility in SDS-PAGE with special reference to the highly acidic extracellular domains of human E- and N-cadherins
10.1002/elps.201800219 ↗29. A novel structurally stable multiepitope protein for HCV detection
30. Abnormal migration of cytosolic proteins by SDS-PAGE can identify domains and mechanisms that control surfactant binding
10.1002/pro.2107 ↗33. Faria, A.R., Veloso, L.d.C., Coura-Vital, W., Reis, A.B., Damasceno, L.M., Gazzinelli, R.T., Andrade, H.M., and Picado, A. (2015). Novel recombinant multiepitope proteins for the diagnosis of asymptomatic Leishmania infantum-infected dogs. PLoS Negl. Trop. Dis., 9.
10.1371/journal.pntd.0003429 ↗36. Potential of recombinant LiHyQ, a novel protein from Leishmania infantum, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus coinfection: A preliminary study
10.1016/j.actatropica.2021.106126 ↗37. Chelbi, I., Maghraoui, K., Zhioua, S., Cherni, S., Labidi, I., Satoskar, A., Hamilton, J.G.C., Zhioua, E., and Barbosa, D.S. (2021). Increased attraction of Leishmania infantum vector sand flies to dogs infected with zoonotic visceral leishmaniasis. PLoS Negl. Trop. Dis., 15.
10.1371/journal.pntd.0009647 ↗40. Rodrigues, R.A.L., Silva, E.S., Giunchetti, R.C., Gonçalves, A.A.M., Lair, D.F., Galdino, A.S., Gandra, I.B., Silva, J.O., Santos, M., and Faria, M.T. (2023). Recombinant Chimeric Multiepitope Protein, Its Obtaining Process, Kit and Method for Diagnosis of Leishmaniasis, and Use. (BR10 2023 017980 0), National Institute of Industrial Property.